company · cik 109657

GT Biopharma, Inc.

GTBPNasdaqSIC 2834public

financials · annual · usd2026

Revenue		$0
Net income		-$28.4M
Total assets		$8.1M
Total liabilities		$1.3M
Equity		$5.8M
Operating cash		-$12.9M

money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1

California, CAhq

signal score · 2026

2026

0.199

STRONG NEG

coverage

15%

why this scoreactive weight 15%

geographic exposure health edge_company_place x score_place_growth · 2026 · +	0.20 w 0.15
insider power player zeroed — blocked: EDGAR ownership doc-fetch (edge_person_company EMPTY) edge_person_company · 2026 · +	0.00 w 0.20
commodity exposure delta zeroed — no data for this cik-year; zeroed edge_commodity_company x e_commodities · 2026 · +	0.00 w 0.12
rate sensitivity zeroed — no data for this cik-year; zeroed c_facts debt x a_rates(treasury_notes) YoY · 2026 · -	0.00 w 0.10
contract momentum zeroed — no data for this cik-year; zeroed b_contracts sum(value_usd) (FY2026 -> 2024) · 2026 · +	0.00 w 0.10
layoff trajectory zeroed — no data for this cik-year; zeroed score_layoff_prediction.probability · 2026 · -	0.00 w 0.10
supply chain proximity zeroed — no data for this cik-year; zeroed edge_company_company degree · 2026 · +	0.00 w 0.08
sentiment zeroed — blocked: k_sentiment/k_youtube EMPTY k_sentiment/k_youtube · 2026 · +	0.00 w 0.07
political tailwind zeroed — no data for this cik-year; zeroed i_fec employee_donations_aggregate · 2026 · +	0.00 w 0.05
private competitor pressure zeroed — blocked: d_private_est EMPTY d_private_est · 2026 · -	0.00 w 0.03

Signal blends rate sensitivity, contract momentum, geographic exposure and more, cross-sectionally normalized per period. Coverage shows how much of the model is currently data-backed — zeroed components are listed in the drill above.